Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma | MicrobiomeTrials
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-07-16Est. Completion: 2030-01-15
Enrollment target: 398 participants
Locations
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California, United States
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States
University of California Davis Comprehensive Cancer Center, Sacramento, California, United States
Saint Mary's Hospital and Regional Medical Center, Grand Junction, Colorado, United States
Alton Memorial Hospital, Alton, Illinois, United States
Decatur Memorial Hospital, Decatur, Illinois, United States
Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois, United States
Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States
Cancer Care Center of O'Fallon, O'Fallon, Illinois, United States
HSHS Saint Elizabeth's Hospital, O'Fallon, Illinois, United States
Memorial Hospital East, Shiloh, Illinois, United States
Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States
UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny, Iowa, United States
Other microbiome trials you might be interested in